ChiCTR2200056894尚未招募1 期
动静脉瘘穿刺方法与透析充分性的关系：一项前瞻性的多中心研究
项目课题资助1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2021年2月18日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 130
- 试验地点
- 1
- 主要终点
- 动静脉透析针之间距离
研究概览
简要总结
确定自体动静脉内瘘使用的各种穿刺方法对透析充分性的影响。
研究设计
- 研究类型
- 观察性研究
- 主要目的
- 横断面
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1、透析期大于等于 3 个月维持性血液透析患者；
- •3、使用自体动静脉内瘘作为血管通路的维持性血液透析患者。
排除标准
- 未提供
研究组 & 干预措施
连续入组
结局指标
主要结局
动静脉透析针之间距离
透析时血流量
透析用针头大小
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Multicenter, parallel, randomized, single-blind trial comparing the efficacy and tolerability of Rhinaction®, an osmotic decongestant nasal spray containing essential oils versus Olynth® 0.1%, a vasoconstrictor, in the relief of acute rhinitis symptoms in adults.Acute rhinitisAdults aged =18years old suffering from acute rhinitis with symptoms present for up to 72h. The purpose of this study is to demonstrate the efficacy and compare safety and tolerability of Medical Device class I Rhinaction® as well as its non-inferiority when compared to Medical Product Olynth® 0.1% in cases of acute rhinitis in adults up to 8 days of administrationEUCTR2015-002796-23-CZaboratoire de la Mer
尚未招募
不适用
Safety and performance of Intraocular LensCTRI/2022/01/039593Omni Lens Pvt Ltd
尚未招募
不适用
Safety and performance of Intraocular LensCTRI/2022/01/039594Omni Lens Pvt Ltd
已完成
2 期
Open-label, single-arm, multicenter, investigators initiated phase II clinical trial to evaluate the efficacy and safety of IDEC-C2B8 in patients with steroid treatment-resistant pemphigussteroid treatment-resistant pemphigusJPRN-UMIN000024265Department of Dermatology, Keio University School of Medicine10
进行中（未招募）
1 期
Study to assess the effects of metyrapone in patients with Cushing’s syndrome during a 12-week treatment periodEUCTR2014-000162-22-DEaboratoire HRA Pharma70